Cargando…
Emerging targets for cancer treatment: S100A9/RAGE
Developing better treatments that work for the majority of patients with brain metastasis (BM) is highly necessary. Complementarily, avoiding those therapeutic procedures that will not benefit a specific patient is also very relevant. In general, existing therapies for patients with BM could be impr...
Autores principales: | Valiente, M., Sepúlveda, J.M., Pérez, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860424/ https://www.ncbi.nlm.nih.gov/pubmed/36652782 http://dx.doi.org/10.1016/j.esmoop.2022.100751 |
Ejemplares similares
-
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
por: Monteiro, Cátia, et al.
Publicado: (2022) -
The S100B/RAGE Axis in Alzheimer's Disease
por: Leclerc, Estelle, et al.
Publicado: (2010) -
Human S100A8 and S100A9 activate phagocytes via Toll-like receptor 4 independent of RAGE
por: Vogl, T, et al.
Publicado: (2009) -
Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein
por: Katte, Revansiddha, et al.
Publicado: (2018) -
S100A8 and S100A9 promote endothelial cell activation through the RAGE-mediated mammalian target of rapamycin complex 2 pathway
por: Zhong, Xiang, et al.
Publicado: (2020)